Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling
American Journal of Translational Research · 2026 · 18 (7) · 5612-5622
DOI: 10.62347/cqyq8046 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Bo Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: To investigate the role of lipopolysaccharide (LPS)-mediated toll-like receptor 4 (TLR4) signaling in modulating the tumor immune microenvironment, particularly the follicular helper T cell (Tfh)/follicular regulatory T cell (Tfr) equilibrium, in bladder cancer. METHODS: MBT-2 and MB49 cells were treated with LPS. TLR4 was knocked down using lentiviral short hairpin RNA. Cell proliferation, migration, and invasion were assessed by methylthiazolyldiphenyl-tetrazolium bromide, scratch, and Transwell assays. A subcutaneous xenograft model in C57BL/6 and C3H/He mice was established. Tfh/Tfr cells in spleens were analyzed by flow cytometry. TLR4 and related cytokine expression were measured by quantitative polymerase chain reaction and western blot. RESULTS: . These pro-tumor effects were reversed by TLR4 knockdown. Furthermore, LPS skewed the Tfh/Tfr ratio in favor of Tfh cells. At the cytokine level, LPS increased the production of interleukin-21 but decreased the levels of forkhead box P3, interleukin-10, and transforming growth factor-beta. All these immunologic alterations were also abolished upon TLR4 knockdown. CONCLUSION: LPS exacerbated bladder cancer progression by activating TLR4 signaling. This disrupts the Tfh/Tfr balance and creates an immunosuppressive niche. Targeting this axis may represent a novel therapeutic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China.
- Department of Laboratory Animal Sciences, Tianjin Medical University Tianjin, China.
- Tianjin International Travel Health Care Center Tianjin, China.
- Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China.
- School of Medical Technology, Tianjin University of Traditional Chinese Medicine Tianjin, China.
Zitieren
APA
Peng, B., Wang, Y., Li, H., Zhuang, C., Guan, R., Zhang, H., & Wan, L. (2026). Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling. American Journal of Translational Research, 18(7), 5612-5622. https://doi.org/10.62347/cqyq8046
Vancouver
Peng B, Wang Y, Li H, Zhuang C, Guan R, Zhang H, et al. Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling. American Journal of Translational Research. 2026;18(7):5612-5622. doi:10.62347/cqyq8046
BibTeX
@article{Peng2026,
author = {Peng, Bo and Wang, Yan and Li, Haochen and Zhuang, Changshui and Guan, Rijian and Zhang, Haopeng and Wan, Lijun},
title = {Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5612--5622},
doi = {10.62347/cqyq8046}
}
EUVIMED